SMYD3 and neoplasm: Nascent tumorigenic cells have been found to activate the SMYD3–H3K4m3 pathway to upregulate CSDE1 expression and stabilize phosphatase, TCPTP, promoting STAT1 dephosphorylation and weakening the immunogenic phenotype of tumor-repopulating cells [18].